OUR COMMITMENT TO ADVANCING THERAPIES FOR CNS DISORDERS IS REFLECTED IN THE BREADTH OF OUR PIPELINE

Today with over 1 billion people affected by neurological disorders, there is a significant unmet need to discover and develop new medicines for patients with central nervous system (CNS) disorders. In our attempt to meet this urgent need, Upsher-Smith will commit significant resources to develop novel drugs and innovative new treatments for patients. Our lead compounds are focused on epilepsy but we will investigate potential treatments for Parkinson’s disease, cognition, neuropathic pain, neuroinflammation, and obesity.

Epilepsy Learn more »

Leadership Learn more »